PURPOSE. Heterotrimeric G proteins are regulated by receptors that act as guanine nucleotide exchange factors (GEFs) and by RGS proteins, which act as guanosine triphosphatase (GTPase) activating proteins (GAPs). Guanosine diphosphate (GDP) dissociation inhibitors (GDIs), such as activators of G protein signaling (AGS)-1 and -3 and Leu-Gly-Asn repeat-enriched (LGN) proteins regulate the Gi family of G proteins. AGS3 and LGN contain four characteristic G protein regulator (GPR) domains that are responsible for its GDI function. This study investigates the presence of a GDI for transducin in photoreceptor cells. METHODS. Western blot analysis of bovine and mouse retina was performed using specific antibodies to AGS and LGN proteins. The subcellular localization of LGN in retina was studied by immunofluorescence microscopy of mouse retinal sections and fractionation of retinal lysates, using sucrose density gradients. The interaction of LGN with transducin was studied using pull-down assays with GST-fused LGN constructs, co-immunoprecipitation and assays for GTP␥S binding.
T he rod phototransduction cascade is a classic G-proteinmediated pathway, where rhodopsin serves as a lightactivated guanine nucleotide exchange factor (GEF) for the G protein transducin. Rhodopsin-activated transducin (Gt) stimulates the effector enzyme cGMP phosphodiesterase through sequestration of its inhibitory ␥ subunit (PDE␥), resulting in a breakdown of cGMP (for review, see Refs. 1,2). The decrease in cGMP levels closes cGMP-gated cation channels and causes a decline in intracellular Na ϩ and Ca 2ϩ and hyperpolarization of the photoreceptor plasma membrane (reviewed in Ref. 3) .
Photoreceptor recovery is achieved by several mechanisms. The decreased concentration of cGMP is restored by retinal guanylate cyclase (for review, see Refs. 4 -6) . The active state of rhodopsin is terminated on rhodopsin phosphorylation by rhodopsin kinase (G protein coupled receptor kinase [GRK1] ) and the subsequent binding of arrestin (for reviews, see Refs. 7, 8) . The guanosine triphosphate (GTP)-bound state of the G protein is terminated by GTP hydrolysis, which is accelerated by the photoreceptor-specific regulator of G protein signaling RGS9-1, which in turn acts as a guanosine triphosphatase (GTPase) activating protein (GAP) for transducin. 9 -11 A new concept in photoreceptor light adaptation has emerged from studies of both vertebrate and invertebrate vision, where adaptation to different light levels occurs through the translocation of signaling proteins to and from the rod outer segment (reviewed in Ref. 12 ). In dark-adapted animals, transducin is predominantly located in the rod outer segments, whereas illumination causes transducin to redistribute to the inner segment and nuclear layer. It is thought that the departure of transducin from the outer segment prevents photoresponse saturation by reducing the amount of available transducin. This translocation is reversed in dark conditions. [13] [14] [15] [16] Recent studies have implicated a novel family of molecules, activator of G protein signaling (AGS) proteins, in the regulation of the G protein cycle (for review, see Refs. 17, 18) . Using a functional screen based on the pheromone-response pathway in Saccharomyces cerevisiae, investigators have identified three proteins that activate the pathway in the absence of a typical receptor. 19 AGS1 is a member of the superfamily of Ras proteins, which acts as a GEF for heterotrimeric G proteins. AGS2 is identical with the light chain component of the cytoplasmic motor protein dynein. The mechanism of regulation of G protein signaling by AGS2 is not understood. AGS3 binds to G␣ subunits preferentially in their GDP-bound form, acts as guanine nucleotide dissociation inhibitor (GDI) for G␣i subunits, and competes for interaction with G␤␥ thus facilitating the activation of G␤␥-dependent effectors. 20, 21 AGS3 possesses a series of seven tetratrico peptide repeat (TPR) motifs and four 20 amino acid repeats termed G-protein regulator (GPR) motifs, also known as Go-Loco motifs. 20 -24 Binding of AGS3 to G␣i occurs through the GPR domain, which is sufficient to stabilize the GDP-bound conformation of G␣i and act as a GDI. 21, 22, 25 Protein interaction studies and/or functional screens in yeast indicate that the AGS3 GPR motif interacts with G␣i1-3, but not G␣z, -12, -s, -q, or -16. 21, 23 Biochemical analysis of the interaction of the recombinant GPR domain of AGS3 with G␣t in vitro has shown that AGS3 can inhibit the rates of rhodopsin-stimulated GTP␥S binding to transducin through the reduced rate of dissociation of GDP from G␣t. 26 Another GPR domain-containing protein was identified as a G␣i-binding protein in a yeast two-hybrid screen. Its deduced amino acid sequence contains 10 Leu-Gly-Asn repeats, and it has thus been named LGN. 27 Similar to AGS3, LGN contains seven TPR domains in its N terminus followed by a linker region and four GPR motifs. The overall amino acid identity between AGS3 and LGN is 59%. While studies in Drosophila and Caenorhabditis elegans and in mammalian cells implicate LGN and some other GPR domain-containing proteins in mitotic spindle organization, very little is known about the role of LGN in regulation of G protein signaling in a physiological system. 28, 29 The presence of AGS and related proteins in photoreceptor cells has not been investigated, and it is not known whether they play a role in regulation of Gt in vivo. Here, we show that photoreceptor inner segments contain LGN. We also provide evidence that LGN interacts with G␣t and can act as a GDI for transducin.
MATERIALS AND METHODS

Antibodies
Two antibodies against LGN were used: anti-LGN linker antibody was raised against a synthetic peptide corresponding to the linker region of LGN (Ser 420 -Lys 449 SEILAKQKPLIAKPSAKLLFVNRLKGKKYK), 21 and and anti-LGN C terminus, was generated in rabbits against a C-terminal peptide (amino acids Phe 653 -His 677 FGLKDFLQNNALLEFKNS-GKKSADH) of human LGN. Both anti-LGN antibodies were affinity purified with their corresponding peptides. The generation of AGS3 and -1 polyclonal antibodies against synthetic peptides has been described previously. 21 The antibody against the ␣ subunit of transducin was obtained from Santa Cruz Biotechnology (Santa Cruz, CA).
Preparation of RIS-ROS Population
The RIS-ROS (the mixture of rod inner segments [RIS] , and rod outer segments [ROS] ) preparations were performed as described by Baker et al. 30 Briefly, dark-adapted bovine retinas (Lawson Co., Lincoln, NE) were thawed in 50% sucrose in ROS buffer (10 mM HEPES [pH 7.2], 5 mM MgSO 4 , and 25 mM KCl) supplemented with a protease inhibitor mixture (1 g/L pepstatin A, 1 g/mL leupeptin, and 4 g/mL aprotinin). The thawed retinas were vortexed for 1 minute to break off the ROS and then filtered through a cheesecloth. After centrifugation at 13,000g for 1 hour at 4°C, the crude ROS-RIS were collected. All the steps were performed under dim red light.
Preparation of ROS Membranes
ROS were prepared from frozen bovine retinas, as described earlier, 31, 32 and passed through a 21-gauge needle five times, and the suspension was centrifuged at 14,000 rpm in a table-top centrifuge for 15 minutes at 4°C. The pellet was further suspended in ROS buffer. The membranes were washed with 6 M urea to remove peripheral membrane proteins.
Preparation of Cytosolic, Membrane, and Cytoskeletal Fractions
The RIS-ROS fraction was passed through a 21-gauge needle, and the suspension was centrifuged at 14,000 rpm for 10 minutes at 4°C. The collected supernatant was designated the cytosolic fraction. The pellet was solubilized in a lysis buffer containing 20 mm Tris (pH 7.4), 1 mM EDTA, 2 mM MgCl 2 , and 1% Triton X-100, supplemented with protease inhibitors, and was centrifuged at 100,000g for 15 minutes. The supernatant contained the detergent-extracted membrane proteins. The detergent-insoluble pellet, which was highly enriched in tubulin, represented the cytoskeletal fraction.
Purification of Recombinant GST-GPR
The glutathione S-transferase (GST) fusion proteins were expressed in Escherichia coli strain BL21 and purified on glutathione-Sepharose 4B (Amersham Pharmacia Biotech, Piscataway, NJ) using a standard protocol. GST-LGN-GPR was constructed by PCR using full-length cDNA for LGN as the template. Primers corresponding to the GPR domain of LGN (Ser 476 -His 677 ; forward primer: 5Ј-GGGGAATTCAGTGCAGATAC-TATTGGAGATGAAGGG-3Ј; reverse primer: 5Ј-ATGCTCGAGCTAATG-GTCTGCCGATTTTTTCCC-3Ј) were designed to add EcoRI and XhoI sites to the 5Ј and 3Ј ends, respectively, of LGN-GPR to fuse the LGN open reading frame with the open reading frame of GST in the pGEX4T1 vector. GST-LGN was constructed by PCR, with a full-length cDNA for LGN used as the template. Primers corresponding to fulllength LGN (Arg 2 -His 677 ; forward primer: 5Ј-AGAGAAGACCATTCTTT-TCATGTTCGT-3Ј; reverse primer: 5Ј-CTAATGGTCTGCCGATTTTT-TCCC-3Ј) were designed to add SalI and NotI sites to the 5Ј and 3Ј ends, respectively, and cloned downstream of GST into the pGEX4T3 vector. The expression of soluble full-length LGN was achieved by lowering the isopropyl-␤-D-thiogalactopyranoside (IPTG) induction temperature to 22°C. The optimal IPTG concentration was 5 M and the time of induction 10 hours. The purity of proteins was tested by polyacrylamide gel electrophoresis in the presence of sodium dodecylsulfate (SDS-PAGE) and found to be Ͼ95%. Protein concentrations were determined by a Bradford protein assay.
GST Pull-Down Assay
Dark-adapted ROS membrane was incubated with GDP or GTP␥S for 10 minutes on ice followed by illumination, and then lysed in buffer containing 20 mM Tris, 150 mM NaCl and 1% Triton X-100, supplemented with protease inhibitors. Triton X-100, supplemented with protease inhibitors. The lysate was preincubated with GST-GPR (1 g) for 15 minutes on ice and followed by an incubation with glutathioneSepharose (20 L). The beads were washed three times with 1 mL lysis buffer, and the bound proteins were eluted with SDS-PAGE sample buffer. The eluates were analyzed by Western blot (1:1000 dilution of the primary anti-G␣t antibodies).
Immunoprecipitation
The crude ROS lysates were precleared with protein A-Sepharose beads, and then incubated overnight, with constant mixing, with 1 g 
Protein Fractionation with Linear Sucrose Gradient
A 100-L aliquot of detergent-solubilized RIS-ROS was layered on top of a 5% to 20% linear sucrose gradient and centrifuged at 35,000 rpm for 16 hours in a rotor (model SW41; Beckman Coulter, Fullerton, CA). Serial fractions (0.5 mL) were collected starting from the top of the tube, resolved on SDS-PAGE, and analyzed by Western blot with anti-LGN (linker region). Sedimentation standards were run in parallel gradients and included thyroglobulin (19S) and catalase (11.5S) as standards.
Immunofluorescence
Mouse eyes were fixed in 0. with primary antibody diluted in PBS (1:100), with 1% BSA, 1% normal goat serum, and 0.1% Triton X-100 for either 2 hours at room temperature or overnight at 4°C. For LGN detection, the anti-LGN linker antibody 28 was used and visualized with FITC-conjugated goat antirabbit IgG, and images were acquired on a laser scanning confocal microscope (LSM 510; Carl Zeiss Meditec, Oberkochen, Germany).
GTP␥S Binding Assay
Preparations of G␣ t and G␤␥ subunits were obtained as described previously. 31 Urea-washed ROS membranes (10 nM rhodopsin) were incubated for 5 minutes at room temperature in 0.5 mL of 20 mM Tris-HCl (pH 7.6) buffer containing 150 mM NaCl and 10 mM MgSO 4 , with or without the addition of varying concentrations of GST-GPR. GTP␥S binding was initiated by the addition of [ 35 S]GTP␥S (0.1 Ci/10 L). Aliquots of 10 L were withdrawn, and subjected to vacuum filtration, using 0.45-m nitrocellulose filters (Millipore, Bedford, MA). The filters were then washed three times with 1 mL ice-cold buffer, dried, and counted in a liquid scintillation counter. Determination of GTP␥S binding at each time point was performed in duplicate.
RESULTS
Our Western blot analysis of bovine and mouse retinal preparations showed the presence of two protein bands, 75 and 30 kDa, recognized by anti-LGN antibodies. At the same time, AGS1 and -3 proteins were not detected in the retina, whereas they were clearly present in the brain. Because AGS3 cDNA was previously amplified from a retinal cDNA library, 26 these results suggest that, whereas AGS3 may also be present at lower amounts, it appears that the major protein representing this family of molecules in the retina is LGN. The 75-kDa protein identified by the anti-LGN antibodies corresponds to the full-length LGN containing the GPR and TPR motifs. 28 The origin of the 30-kDa protein is not clear, but it possibly represents a splice variant of LGN that is similar to a previously described variant of AGS3 lacking the TPR domains 33 ( Fig. 1 ). Both the 75-and 30-kDa species were detected by antibodies generated against two distinct parts of the LGN molecule, the linker region and the C terminus, confirming the presence of LGN in the retina.
The presence of LGN in the retina was further investigated by immunofluorescence microscopy. LGN was mainly localized in the inner segments of mouse retina, outer nuclear layer, and synaptic terminals of photoreceptors, but was not detected in the outer segments. Light did not affect the distribution of LGN (Fig. 2) , whereas G␣t translocated from ROS to the inner segments in response to light, in agreement with previous reports. [13] [14] [15] [16] We then studied the distribution of LGN between the cytosolic, membrane and cytoskeletal fractions in a crude rod cell preparation enriched in rod outer and inner segments (RIS-ROS fraction). The full-length LGN was present in all three fractions, whereas the 30-kDa variant was absent in the cytoskeletal fraction (Fig. 3A) . TPR domains, found in several other proteins, are known to mediate protein-protein interactions and assembly of multiprotein complexes. 34 Because LGN has seven TPR motifs, we tested to determine whether LGN also exists as a part of a high-molecular-mass complex. The RIS-ROS lysate was analyzed by ultracentrifugation on a sucrose density gradient. We found that 10% to 15% of 75-kDa LGN migrated in the high-molecular-mass fractions in the range of 17S to 20S (Fig. 3B) .
The presence of GPR motifs in LGN promotes its interaction with the G␣i family. Therefore, to investigate the potential interaction between LGN and transducin, we subjected ROS membrane lysates to pull-down assays, by using the GST fusions of full-length LGN and its GPR domain. In the presence of GDP, both GST-LGN and GST-GPR bound robustly to G␣t (Fig.  4A) , whereas G␣t did not bind to the beads with immobilized GST (not shown). When the lysate was prepared after incuba- tion of membranes with GTP␥S, no interaction was detected. This shows that LGN interacts exclusively with the GDP-bound form of G␣t. To investigate the interaction between endogenous LGN and transducin, we immunoprecipitated the G␣ t -LGN complex from the rod cell lysates, using either anti-G␣t (Fig. 4B) or anti-LGN (Fig. 4C) antibodies. LGN and G␣t coimmunoprecipitated in both versions of the assay, indicating that transducin and LGN interact in situ. Like its recombinant counterpart, endogenous LGN only bound to the GDP-bound transducin, as their co-immunoprecipitation was drastically reduced by GTP␥S (Figs. 4B, 4C) .
To ascertain whether LGN can function as a GDI for transducin, we measured its effect on the rate of rhodopsin-induced [ 35 S]GTP␥S binding to transducin. Figure 5 shows that in the presence of the GST-GPR domain of LGN, GTP␥S binding was significantly reduced, indicating that LGN can potentially act as a GDI for transducin.
We next assessed the amount of LGN in photoreceptors relative to G␣t by quantitative Western blot analysis. There is no established technique for isolation of homogeneous intact photoreceptor cells, and because LGN is a ubiquitous protein, determining the exact amount of LGN in photoreceptors is difficult. Therefore, we estimated the expression level of LGN in our RIS-ROS preparation. We calibrated the Western blot signal with an anti-LGN antibody and known amounts of GST-LGN and used it to determine the amount of LGN in the RIS-ROS lysate (Fig. 6A) . In parallel, the amount of transducin in the same preparation was determined by Coomassie staining, using purified transducin as a standard (Fig. 6B) . Our results show that the ratio of LGN to transducin was approximately 1:15, an amount sufficient to exert an effect on transducin function.
DISCUSSION
We demonstrated the presence of LGN in photoreceptor cells and showed that LGN can interact with G␣t in its GDP-bound state. Our data also show that LGN can inhibit GTP␥S binding to transducin, indicating that it can potentially act as a GDI for this G protein. Because it is not present in the outer segments, it is unlikely that LGN plays a direct role in the regulation of phototransduction. This is consistent with the intrinsic biochemical properties of G␣t, which cannot exchange GDP for GTP in the absence of active rhodopsin. In contrast, other members of the G␣i family can exchange GDP for GTP spontaneously, and therefore require a GDI to keep their basal activity low.
Recent studies have demonstrated the translocation of Gt from the outer to inner segments in response to light. This process has been implicated in light adaptation, because it reduces the amount of transducin available to carry signals from rhodopsin to PDE. 16 Because LGN is not present in the outer segment, it can only interact with transducin on its arrival to the inner segment. The role of this interaction could be to prevent G␣t interference with other G-protein-mediated signaling events in the inner segment. Because G␣t translocation precedes that of transducin G␤␥, 16 it is possible that free G␣t competes with other G␣ subunits for their G␤␥ subunits. For efficient sequestration of G␣t, LGN must be present in amounts that are comparable to that of G␣t. We estimated the LGN-to-transducin ratio in our rod cell preparations to be approximately 1:15. However, this amount is likely to be a significant underestimation, because our RIS-ROS preparation was enriched in ROS and depleted of RIS. Furthermore, complete translocation of transducin to the inner segment requires extremely bright light. Under physiological conditions, only a small pool of G␣t moves to the inner segments, and so the relatively less-abundant LGN could still be sufficient for neutralizing the potential negative effects of free G␣t, at least until the arrival of transducin's G␤␥. Moreover, because LGN has four GPR domains, it can potentially bind more than one G␣t. Indeed, AGS3 has been shown to bind four G␣i subunits simultaneously through its four GPR domains. 21, 22 The reassociation of heterotrimeric transducin could occur on the arrival of G␤␥ to the inner segment, eventually leading to the return of transducin to the outer segment.
It is known that several TPR domain-containing proteins participate in formation of multimeric protein complexes, probably because of the interaction of TPR domains with common acceptor molecules. 34 For example, interflagellar transport (IFT) in photoreceptors involves assembly of a large complex containing IFT88, a protein with 10 TPR motifs. Cycling of the IFT complex between the axoneme and cell body is thought to be associated with transport of essential "cargo" proteins. 35 We hypothesized that LGN is involved in the transport of transducin, by serving as an adaptor protein linking the IFT complex with G␣t. However, LGN and IFT88 did not co-immunoprecipitate (data not shown), and so it appears that LGN is a part of a distinct large protein complex. Another interesting observation is that a significant portion of full-length LGN is associated with the cytoskeleton, whereas the 30-kDa species is not, probably because it lacks the TPR domains.
While the presence of LGN in photoreceptor cells and its interaction with G␣t strongly suggests that it has a role in the regulation of transducin function, we cannot rule out that it regulates other G proteins or another cellular activity. Understanding the role of LGN in photoreceptors necessitates further experiments involving photoreceptor-specific knockout of the LGN gene and disruption of the transducin-LGN interaction using transgenic mice models. 
